Beta Bionics Inc
NASDAQ:BBNX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hillenbrand Inc
NYSE:HI
|
US |
|
Jiangsu Skyray Instrument Co Ltd
SZSE:300165
|
CN |
|
Resource Alam Indonesia Tbk PT
IDX:KKGI
|
ID |
|
CRH PLC
LSE:CRH
|
IE |
|
A
|
Arise AB
STO:ARISE
|
SE |
|
X
|
Xinjiang Machinery Research Institute Co Ltd
SZSE:300159
|
CN |
|
TreeHouse Foods Inc
NYSE:THS
|
US |
|
S
|
Silk Road Logistics Holdings Ltd
HKEX:988
|
HK |
|
S
|
Skjern Bank A/S
LSE:0G19
|
DK |
|
P
|
Parque Arauco SA
SGO:PARAUCO
|
CL |
Beta Bionics Inc
EPS (Diluted)
Beta Bionics Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Beta Bionics Inc
NASDAQ:BBNX
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
63%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
EPS (Diluted)
$1
|
CAGR 3-Years
-9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$8
|
CAGR 3-Years
11%
|
CAGR 5-Years
15%
|
CAGR 10-Years
8%
|
|
|
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$3
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$7
|
CAGR 3-Years
29%
|
CAGR 5-Years
22%
|
CAGR 10-Years
16%
|
|
Beta Bionics Inc
Glance View
Beta Bionics, Inc. is a commercial-stage medical device company. The company is headquartered in Irvine, California and currently employs 279 full-time employees. The company went IPO on 2025-01-30. The firm's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The firm's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The firm is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. The company is also in the early stages of developing a bihormonal configuration of the iLet.
See Also
What is Beta Bionics Inc's EPS (Diluted)?
EPS (Diluted)
-1.8
USD
Based on the financial report for Dec 31, 2025, Beta Bionics Inc's EPS (Diluted) amounts to -1.8 USD.
What is Beta Bionics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-6%
Over the last year, the EPS (Diluted) growth was -41%. The average annual EPS (Diluted) growth rates for Beta Bionics Inc have been -6% over the past three years .
